Andreea R. Schmitzer
Montreal, QC H2V0B3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Mitochondria-targeting symmetric diiminoguanidines: potent and selective anticancer agents against pancreatic tumors.
Journal: RSC medicinal chemistry
Published: September 11, 2025
Mitochondria-Targeting Biquaternary Ammonium Compounds: Pancreatic Anticancer Activity and Synergistic Interaction with Metformin.
Journal: ACS bio & med chem Au
Published: November 25, 2024
Effects of Biguanide-PROTACs in Pancreatic Cancer Cells.
Journal: Molecules (Basel, Switzerland)
Published: October 01, 2024
Gaining Insight into Mitochondrial Targeting: AUTAC-Biguanide as an Anticancer Agent.
Journal: Molecules (Basel, Switzerland)
Published: July 10, 2024
Confronting the Threat: Designing Highly Effective bis-Benzimidazolium Agents to Overcome Biofilm Persistence and Antimicrobial Resistance.
Journal: ACS infectious diseases
Published: October 26, 2023
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells.
Journal: Cancers
Published: August 08, 2022
Phytochemical- and Cyclodextrin-Based Pickering Emulsions: Natural Potentiators of Antibacterial, Antifungal, and Antibiofilm Activity.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: April 10, 2020
Benzimidazolium salts prevent and disrupt methicillin-resistant Staphylococcus aureus biofilms.
Journal: RSC advances
Published: January 23, 2020
Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth.
Journal: Scientific reports
Published: October 02, 2019
Anti-staphylococcal biofilm activity of miconazoctylium bromide.
Journal: Organic & biomolecular chemistry
Published: May 26, 2018
Last Updated: 09/26/2026